Developer docs
API playgroundTry for free, no card

Search company profiles

EntityRisk

Full company profile

uuid0008meh

Namestring
EntityRisk
Legal namestring
EntityRisk
Websiteurl
entityrisk.com
Company typeenum
Private
Founded yearint
2013
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPrinceton, United States
HQ citystring
Princeton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
health economics software, value-based pricing, pharmaceutical analytics, outcomes research platform, evidence generation planning
Industry3 codes
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code2 codes
  • Software Publishers51321
  • Scientific Research and Development Services5417
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Health Economics Software / HEOR Analytics Platform
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Software Platform Licensing/Subscription
TypeSubscription Recurring
Description

PROVEN platform delivered as software-as-a-service to biopharma companies for health economic modeling, pricing analysis, and evidence generation. Likely subscription-based model given enterprise B2B nature.

entityrisk.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

EntityRisk sells PROVEN™, a software-as-a-service platform that integrates health economics and policy expertise with machine learning and Bayesian methods to predict real-world health outcomes, simulate value-based pricing, prioritize evidence-generation investments, and forecast commercial revenue for biopharmaceutical products. The platform comprises five ML modules (OutcomesML™, ValueML™, EvidenceML™, PriceML™, CommercialML™) and is delivered to biopharma companies, biotech firms, healthcare investors, and diagnostics companies via enterprise subscriptions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Base-case value-based price 84% higher vs ICER assessments
+4 more records
Product overview1 text field

EntityRisk offers PROVEN™ as a unified, modular software platform for health economics and outcomes research. The platform consists of five specialized ML modules—OutcomesML™, ValueML™, EvidenceML™, PriceML™, and CommercialML™—that work together to provide comprehensive health outcome predictions, value-based pricing simulations, evidence quantification, price forecasting, and revenue projections. Built on Python with a modular architecture, PROVEN™ integrates clinical trial data, real-world data, and financial data to generate probabilistic predictions for biopharma decision-making.

Product and service6 records
1PROVEN™ Platform
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Advanced health economic modeling software platform built on a Python core with modular design that uses machine learning and Bayesian methods to predict health outcomes, identify value-based pricing, and substantiate evidence-generation investments for biopharma companies and healthcare investors.

2OutcomesML™
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Module of PROVEN™ that predicts the distribution of real-world health outcomes for pipeline or marketed products from clinical trial data (including surrogate endpoints and biomarkers), real-world data, and/or target product profiles (TPPs).

3ValueML™
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Module of PROVEN™ that simulates a full array of justifiable value-based prices, budget impact, and cost-effectiveness outcomes using multiple value-assessment frameworks simultaneously to support pricing strategies, payer negotiations, and HTA submissions.

4EvidenceML™
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Module of PROVEN™ that directly links evidence to impact and quantifies the elasticity and risk surrounding product or population characteristics to prioritize evidence investments, optimize trial design, and establish and update TPPs and product forecasts.

5PriceML™
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Module of PROVEN™ that predicts the likely distribution of real-world WAC and net prices for any given target product profile.

6CommercialML™
CategoryHealth Economics Software / HEOR Analytics Platform
Description

Module of PROVEN™ that forecasts long-term revenues and downside risks over a product lifecycle across pricing, contracting, efficacy, and competitive scenarios.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-18
Description

Partnership with Cleo Diagnostics to provide evidence-based insight into the economic value of Cleo's Ovarian Cancer Pre-Surgical Test in the U.S. market. EntityRisk is conducting a health economic study to support U.S. market entry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EntityRisk

Health Economics Software / HEOR Analytics Platformentityrisk.com

EntityRisk firmographics

Firmographics
Name
EntityRisk
Legal name
EntityRisk
Website
https://entityrisk.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

EntityRisk industry classification

Industry
Product category
Health Economics Software / HEOR Analytics Platform
NAICS
Software Publishers (51321), Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAIAKAC
Value Dossier & Evidence Generation (AMCP/Global Value Dossier)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SECONDARYHLAGAJAM
Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAOAN
Market Access, Pricing & Reimbursement (Evidence Generation) FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Health economics software
  • Value-based pricing
  • Pharmaceutical analytics
  • Outcomes research platform
  • Evidence generation planning

Where EntityRisk is headquartered

Location

Headquarters

HQ city
Princeton
HQ country
United States
HQ region
North America

Markets served

EntityRisk business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Software Platform Licensing/Subscription: PROVEN platform delivered as software-as-a-service to biopharma companies for health economic modeling, pricing analysis, and evidence generation. Likely subscription-based model given enterprise B2B nature.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

EntityRisk product offering

Product offering

Core offering

EntityRisk sells PROVEN™, a software-as-a-service platform that integrates health economics and policy expertise with machine learning and Bayesian methods to predict real-world health outcomes, simulate value-based pricing, prioritize evidence-generation investments, and forecast commercial revenue for biopharmaceutical products. The platform comprises five ML modules (OutcomesML™, ValueML™, EvidenceML™, PriceML™, CommercialML™) and is delivered to biopharma companies, biotech firms, healthcare investors, and diagnostics companies via enterprise subscriptions.

Product overview

EntityRisk offers PROVEN™ as a unified, modular software platform for health economics and outcomes research. The platform consists of five specialized ML modules—OutcomesML™, ValueML™, EvidenceML™, PriceML™, and CommercialML™—that work together to provide comprehensive health outcome predictions, value-based pricing simulations, evidence quantification, price forecasting, and revenue projections. Built on Python with a modular architecture, PROVEN™ integrates clinical trial data, real-world data, and financial data to generate probabilistic predictions for biopharma decision-making.

Differentiator

Problem solved

Functional benefit

Products and services

  • PROVEN™ Platform Advanced health economic modeling software platform built on a Python core with modular design that uses machine learning and Bayesian methods to predict health outcomes, identify value-based pricing, and substantiate evidence-generation investments for biopharma companies and healthcare investors.
  • OutcomesML™ Module of PROVEN™ that predicts the distribution of real-world health outcomes for pipeline or marketed products from clinical trial data (including surrogate endpoints and biomarkers), real-world data, and/or target product profiles (TPPs).
  • ValueML™ Module of PROVEN™ that simulates a full array of justifiable value-based prices, budget impact, and cost-effectiveness outcomes using multiple value-assessment frameworks simultaneously to support pricing strategies, payer negotiations, and HTA submissions.
  • EvidenceML™ Module of PROVEN™ that directly links evidence to impact and quantifies the elasticity and risk surrounding product or population characteristics to prioritize evidence investments, optimize trial design, and establish and update TPPs and product forecasts.
  • PriceML™ Module of PROVEN™ that predicts the likely distribution of real-world WAC and net prices for any given target product profile.
  • CommercialML™ Module of PROVEN™ that forecasts long-term revenues and downside risks over a product lifecycle across pricing, contracting, efficacy, and competitive scenarios.

Quantifiable outcome

  • Base-case value-based price 84% higher vs ICER assessments
  • +4 more outcomes

Companies that use EntityRisk

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

EntityRisk technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature9 records

EntityRisk partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Cleo DiagnosticscoreStrategic or Co-development Partner · 18 August 2025Partnership with Cleo Diagnostics to provide evidence-based insight into the economic value of Cleo's Ovarian Cancer Pre-Surgical Test in the U.S. market. EntityRisk is conducting a health economic study to support U.S. market entry.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

EntityRisk competitors and assessment

Company assessment

Market position

Competitive moat4 records

Key risks6 records

Customer concentration

EntityRisk social profiles

Digital presence

EntityRisk financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EntityRisk leadership team

Management profile

Number of profiles

Profiles20 records

EntityRisk funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EntityRisk M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EntityRisk

What does EntityRisk do?

EntityRisk sells PROVEN™, a software-as-a-service platform that integrates health economics and policy expertise with machine learning and Bayesian methods to predict real-world health outcomes, simulate value-based pricing, prioritize evidence-generation investments, and forecast commercial revenue for biopharmaceutical products. The platform comprises five ML modules (OutcomesML™, ValueML™, EvidenceML™, PriceML™, CommercialML™) and is delivered to biopharma companies, biotech firms, healthcare investors, and diagnostics companies via enterprise subscriptions.

Is EntityRisk a public or private company?

EntityRisk is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was EntityRisk founded?

EntityRisk was founded in 2013. It employs 11 to 50 people.

Where is EntityRisk based?

EntityRisk is headquartered in Princeton, United States, in the North America region.

How does EntityRisk make money?

One revenue line is on record: software Platform Licensing/Subscription.

Does EntityRisk have an API?

No public API is recorded for EntityRisk.

What industry is EntityRisk in?

EntityRisk's product category is Health Economics Software / HEOR Analytics Platform. Its primary akta.pro industry code is HLAIAKAC, Value Dossier & Evidence Generation (AMCP/Global Value Dossier), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 51321 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals